54.09USD-0.02%Mkt Cap: 10.45B USDP/E: 38.91Last update: 2026-05-22
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap10.45B USD
Enterprise Value9.67B USD
Revenue (TTM)3.24B USD
Gross Profit2.50B USD
Net Income (TTM)348.90M USD
Revenue/Share16.87 USD
Last Price54.09 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS09061G1013
Valuation
P/E (Trailing)38.91
P/E (Forward)8.40
PEG0.43
EV/EBITDA15.32
EV/Revenue2.98
P/S3.23
P/B1.68
EPS (TTM)1.39
EPS (Forward)6.44
52W Range
49.2628% of range66.28
52W High66.28 USD
52W Low49.26 USD
Profitability
Gross Margin77.73%
Oper. Margin18.00%
EBITDA Margin19.47%
Profit Margin10.83%
ROE5.73%
ROA4.59%
Growth
Revenue Growth2.80%
Earnings Growth-43.10%
Cash Flow & Leverage
Operating CF827.99M USD
CapEx (TTM)110.97M USD
FCF Margin14.17%
FCF Yield4.39%
Net Debt-782.83M USD
Net Debt/EBITDA-1.24
Balance Sheet
Debt/Equity0.10
Current Ratio5.81
Quick Ratio3.94
Book Value/Sh32.14 USD
Cash/Share11.50 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)87.92 USD
Target Range50.00 USD – 120.00 USD
# Analysts26
Ownership
Shares Out.193.28M
Float192.17M
Insiders0.30%
Institutions102.82%
Short Interest
Short Ratio6.9d
Short % Float5.60%
Short % Out.5.58%
Shares Short10.79M
Short (prev mo.)8.83M
Technical
SMA 5054.56 (-0.9%)
SMA 20055.94 (-3.3%)
Beta0.23
S&P 52W Chg28.31%
Avg Vol (30d)1.98M
Avg Vol (10d)2.38M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—